Literature DB >> 20456645

An unusual cause of abnormal intrathoracic impedance in a patient with arrhythmogenic right ventricular cardiomyopathy.

Daniel B Kramer1, William H Maisel.   

Abstract

A device interrogation for a 32-year-old woman with arrhythmogenic right ventricular cardiomyopathy and an implantable cardioverter-defibrillator capable of monitoring intrathoracic impedance demonstrated a dramatic increase in her OptiVol Fluid index levels in the absence of clinical heart failure. The timing of her intrathoracic impedance changes correlated with plasma volume changes during an uneventful pregnancy without cardiovascular complications. The strengths and limitations of intrathoracic impedance are described in the context of the physiology of pregnancy. ©2010, The Authors. Journal compilation ©2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20456645     DOI: 10.1111/j.1540-8159.2010.02774.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  3 in total

1.  Influence of lung volume, fluid and capillary recruitment during positional changes and exercise on thoracic impedance in heart failure.

Authors:  Chul-Ho Kim; Matthew A Fuglestad; Maile L Ceridon Richert; Win K Shen; Bruce D Johnson
Journal:  Respir Physiol Neurobiol       Date:  2014-08-14       Impact factor: 1.931

2.  Feasibility of using multivector impedance to monitor pulmonary congestion in heart failure patients.

Authors:  Philip F Binkley; James G Porterfield; Linda M Porterfield; Scott L Beau; Raffaele Corbisiero; G Stephen Greer; Charles J Love; Melanie Turkel; Anders Bjorling; Fujian Qu; Taraneh G Farazi
Journal:  J Interv Card Electrophysiol       Date:  2012-06-12       Impact factor: 1.900

3.  OptiVol fluid index predicts acute decompensation of heart failure with a high rate of unexplained events.

Authors:  Xin-Wei Yang; Wei Hua; Li-Gang Ding; Jing Wang; Li-Hui Zheng; Chong-Qiang Li; Zhi-Min Liu; Ke-Ping Chen; Shu Zhang
Journal:  J Geriatr Cardiol       Date:  2013-09       Impact factor: 3.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.